Advertisement
Calliditas Therapeutics Ab

Calliditas Therapeutics Ab (CLTEF) Stock Competitors & Peer Comparison

See (CLTEF) competitors and their performances in Stock Market.

CLTEFPNK
TechnologySoftware - Application
$0.25
$0.02(9.34%)
U.S. Market opens in 4h 7m
Advertisement

Peer Comparison Table: Software - Application Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CLTEF$0.25+9.34%14.7MN/AN/AN/A
SFCX$0.06+3.28%17.4MN/AN/AN/A
RBLK$1.08+0.00%640KN/AN/AN/A
RTCJF$0.01+3.70%411KN/A-$64.80N/A
TKMOD$0.04-28.70%185.6K0.22$0.16N/A
MDDM$0.00+0.00%3.8KN/AN/AN/A
STIXD$0.00+0.00%0-0.00-$153.49N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CLTEF vs SFCX Comparison June 2026

CLTEF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CLTEF stands at 14.7M. In comparison, SFCX has a market cap of 17.4M. Regarding current trading prices, CLTEF is priced at $0.25, while SFCX trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CLTEF currently has a P/E ratio of N/A, whereas SFCX's P/E ratio is N/A. In terms of profitability, CLTEF's ROE is -0.65%, compared to SFCX's ROE of -0.15%. Regarding short-term risk, CLTEF is more volatile compared to SFCX. This indicates potentially higher risk in terms of short-term price fluctuations for CLTEF.Check SFCX's competition here

Stock price comparison of stocks in the Technology Sector

Loading...

Frequently Asked Questions